This article has no abstract; the first 100 words appear below.
The preferred contemporary approach to the management of stable ischemic heart disease, also referred to as chronic coronary syndrome,1 is not well defined. Two strategies are…
From the Department of Medicine, Stanford University School of Medicine, Stanford (D.J.M., R.A.H.), and Cedars–Sinai Medical Center, Los Angeles (D.S.B.) — both in California; New York University Grossman School of Medicine (J.S.H., H.R.R., S. Bangalore,…
Anatomic severity of disease—but not severity of ischemia—predicted the risk of death or MI over 4 years of follow-up in the ISCHEMIA…
WASHINGTON (Mar 28, 2020) – An international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary intervention (PCI) did not meet its stated goal for cutting in half the…
The effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized or had received intravenous diuretic therapy is…
The St. Paul City Council is considering banning conversion therapy for minors, with an ordinance that would impose fines on licensed medical professionals who practice it.
Conversion therapy, which seeks to change someone’s sexual orientation or gender…
SAN DIEGO — As the number of coronavirus cases and deaths continues to climb, doctors, scientists, and health officials are in a race against time to find treatments that work.
While there are no FDA-approved drugs to specifically treat…
LONDON–(BUSINESS WIRE)–Mar 26, 2020–
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused…
As the coronavirus continues to spread across the globe, the news is coming at a fast and furious pace. But don’t let…
